Somewhat Positive Press Coverage Somewhat Unlikely to Impact Intermolecular (IMI) Stock Price

Media headlines about Intermolecular (NASDAQ:IMI) have been trending somewhat positive recently, Accern reports. The research firm identifies positive and negative media coverage by reviewing more than twenty million news and blog sources in real-time. Accern ranks coverage of companies on a scale of negative one to positive one, with scores nearest to one being the most favorable. Intermolecular earned a media sentiment score of 0.17 on Accern’s scale. Accern also assigned news coverage about the semiconductor company an impact score of 45.4135950570727 out of 100, meaning that recent media coverage is somewhat unlikely to have an effect on the company’s share price in the next several days.

Separately, ValuEngine upgraded Intermolecular from a “sell” rating to a “hold” rating in a research report on Sunday, December 31st.

Intermolecular (NASDAQ:IMI) traded down $0.04 during trading hours on Friday, reaching $1.42. The company’s stock had a trading volume of 96,000 shares, compared to its average volume of 79,500. Intermolecular has a 12 month low of $0.80 and a 12 month high of $1.65. The stock has a market capitalization of $72.36, a P/E ratio of -5.07 and a beta of 1.15.

Intermolecular (NASDAQ:IMI) last posted its earnings results on Thursday, November 2nd. The semiconductor company reported ($0.04) EPS for the quarter. Intermolecular had a negative net margin of 36.38% and a negative return on equity of 34.24%.

ILLEGAL ACTIVITY NOTICE: “Somewhat Positive Press Coverage Somewhat Unlikely to Impact Intermolecular (IMI) Stock Price” was reported by Transcript Daily and is the sole property of of Transcript Daily. If you are viewing this piece on another domain, it was copied illegally and republished in violation of United States & international copyright & trademark law. The correct version of this piece can be accessed at

Intermolecular Company Profile

Intermolecular, Inc provides thin film solutions. The Company’s high productivity combinatorial (HPC) platform, which consists of its tempus processing tools, its automated characterization methods, and its Informatics analysis software, is purpose-built for research and development (R&D) using combinatorial process systems.

Insider Buying and Selling by Quarter for Intermolecular (NASDAQ:IMI)

Receive News & Ratings for Intermolecular Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Intermolecular and related companies with's FREE daily email newsletter.

Leave a Reply